Correlation Between BeiGene and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BeiGene and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BeiGene and Terns Pharmaceuticals, you can compare the effects of market volatilities on BeiGene and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and Terns Pharmaceuticals.
Diversification Opportunities for BeiGene and Terns Pharmaceuticals
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between BeiGene and Terns is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of BeiGene i.e., BeiGene and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between BeiGene and Terns Pharmaceuticals
Given the investment horizon of 90 days BeiGene is expected to generate 0.62 times more return on investment than Terns Pharmaceuticals. However, BeiGene is 1.6 times less risky than Terns Pharmaceuticals. It trades about -0.3 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest 22,101 in BeiGene on August 24, 2024 and sell it today you would lose (3,124) from holding BeiGene or give up 14.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
BeiGene vs. Terns Pharmaceuticals
Performance |
| Timeline |
| BeiGene |
| Terns Pharmaceuticals |
BeiGene and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BeiGene and Terns Pharmaceuticals
The main advantage of trading using opposite BeiGene and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| BeiGene vs. Ascendis Pharma AS | BeiGene vs. Apellis Pharmaceuticals | BeiGene vs. Akero Therapeutics | BeiGene vs. Blueprint Medicines Corp |
| Terns Pharmaceuticals vs. Lyra Therapeutics | Terns Pharmaceuticals vs. Hookipa Pharma | Terns Pharmaceuticals vs. Cingulate Warrants | Terns Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |